====== Momordin-Ic 10μM R08 exp506 ====== ==== Mechanism of Action ==== Triterpenoid saponin, putative SUMO-specific protease 1 (SENP1) inhibitor * **Class / Subclass 1:** Uncharacterized Mechanism / Traditional Medicine * **Class / Subclass 2:** Proteostasis / SUMOylation Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%Momordin Ic%% * **Synonyms:** N/A * **CAS #:** 96990-18-0 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/176596|176596]] * **IUPAC:** %%(2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,5-dihydroxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxane-2-carboxylic acid%% * **INCHI Name:** InChI=1S/C41H64O13/c1-36(2)14-16-41(35(49)50)17-15-39(6)20(21(41)18-36)8-9-24-38(5)12-11-25(37(3,4)23(38)10-13-40(24,39)7)52-34-29(46)30(28(45)31(54-34)32(47)48)53-33-27(44)26(43)22(42)19-51-33/h8,21-31,33-34,42-46H,9-19H2,1-7H3,(H,47,48)(H,49,50)/t21-,22+,23-,24+,25-,26-,27+,28-,29+,30-,31-,33-,34+,38-,39+,40+,41-/m0/s1 * **INCHI Key:** HWYBGIDROCYPOE-WEAQAMGWSA-N * **Molecular Weight:** 764.9 * **Canonical SMILES:** CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)OC7C(C(C(CO7)O)O)O)O)C)C)C2C1)C)C(=O)O)C * **Isomeric SMILES:** C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O * **Molecular Formula:** C41H64O13 {{:chemogenomics:structures:chem-0311.svg?nolink}} * **Supplier Name:** Toronto Research Chemicals * **Catalog #:** M638000 * **Lot #:** 3-MJJ-12-1 * **HRMS (ESI-TOF) m/z:** (M+Na)+ Calcd for C41H64O13 787.42391; found 787.42417 * **Platform ID:** Momordin_Ic * **Min:** -1.9695; **Max:** 99.7054 {{:chemogenomics:dose_response:dr_559.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |6.1700 | | IC20 |8.2940 | | IC30 |10.1000 | | IC40 |11.8600 | | IC50 |13.7500 | | IC60 |15.9500 | | IC70 |18.7300 | | IC80 |22.8100 | | IC90 |30.6600 | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 10µM * **Days of incubation**: 8 * **Doublings**: 6.0 * **Numbers of reads**: 17038529 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |11/1|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Momordin_Ic_10uM_Round-8_exp506.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp506.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:C:CSTB|CSTB]]|-4.47|<0.01| |[[:human_genes:S:SPTLC1|SPTLC1]]|-3.77|<0.01| |[[:human_genes:S:SPTLC2|SPTLC2]]|-3.69|<0.01| |[[:human_genes:F:FDPS|FDPS]]|-3.59|<0.01| |[[:human_genes:R:RNH1|RNH1]]|-3.36|<0.01| |[[:human_genes:D:DNAJC13|DNAJC13]]|-3.30|<0.01| |[[:human_genes:K:KDSR|KDSR]]|-3.17|<0.01| |[[:human_genes:R:RSRC2|RSRC2]]|-3.10|0.20| |[[:human_genes:S:SPTSSA|SPTSSA]]|-3.03|<0.01| |[[:human_genes:T:TCF4|TCF4]]|-3.01|<0.01| |[[:human_genes:A:ARL1|ARL1]]|-2.79|<0.01| |[[:human_genes:Y:YLPM1|YLPM1]]|-2.77|0.09| |[[:human_genes:C:CHMP5|CHMP5]]|-2.64|0.01| |[[:human_genes:G:GALE|GALE]]|-2.46|0.07| |[[:human_genes:E:EMC1|EMC1]]|-2.38|0.06| |[[:human_genes:N:NSFL1C|NSFL1C]]|-2.37|0.06| |[[:human_genes:C:COL4A3BP|COL4A3BP]]|-2.34|0.07| |[[:human_genes:F:FKTN|FKTN]]|-2.20|0.13| |[[:human_genes:H:HSD17B12|HSD17B12]]|-2.19|0.30| |[[:human_genes:S:SMG8|SMG8]]|-2.14|0.17| |[[:human_genes:K:KDR|KDR]]|-2.13|0.30| |[[:human_genes:G:GPR101|GPR101]]|-2.07|0.23| |[[:human_genes:G:GEMIN4|GEMIN4]]|-2.06|0.30| |[[:human_genes:G:GPR107|GPR107]]|-2.03|0.28| |[[:human_genes:S:SHOC2|SHOC2]]|-2.02|0.30| |[[:human_genes:T:TSSC1|TSSC1]]|-2.00|0.30| |[[:human_genes:N:NAA20|NAA20]]|-1.98|0.30| |[[:human_genes:A:ADIPOR1|ADIPOR1]]|-1.97|0.30| |[[:human_genes:S:SLC11A2|SLC11A2]]|-1.97|0.30| |[[:human_genes:T:TRIAP1|TRIAP1]]|-1.95|0.50| |[[:human_genes:A:ADO|ADO]]|1.96|0.50| |[[:human_genes:G:GOLGA6L1|GOLGA6L1]]|1.97|0.83| |[[:human_genes:D:DHX8|DHX8]]|1.97|0.72| |[[:human_genes:S:SLC25A37|SLC25A37]]|1.99|0.50| |[[:human_genes:M:MMP15|MMP15]]|2.00|0.49| |[[:human_genes:K:KIAA0195|KIAA0195]]|2.01|0.50| |[[:human_genes:E:ERAP1|ERAP1]]|2.03|0.50| |[[:human_genes:C:CREB3L3|CREB3L3]]|2.03|0.44| |[[:human_genes:N:NARFL|NARFL]]|2.04|0.77| |[[:human_genes:S:SAMD9L|SAMD9L]]|2.04|0.44| |[[:human_genes:R:RRS1|RRS1]]|2.05|0.59| |[[:human_genes:U:UBE4A|UBE4A]]|2.08|0.42| |[[:human_genes:M:MME|MME]]|2.08|0.42| |[[:human_genes:K:KCTD2|KCTD2]]|2.08|0.42| |[[:human_genes:C:C12orf66|C12orf66]]|2.09|0.50| |[[:human_genes:K:KIAA1239|KIAA1239]]|2.14|0.41| |[[:human_genes:D:DEPDC5|DEPDC5]]|2.16|0.44| |[[:human_genes:N:NAA60|NAA60]]|2.16|0.41| |[[:human_genes:P:POLD2|POLD2]]|2.19|0.53| |[[:human_genes:I:ITFG2|ITFG2]]|2.21|0.37| |[[:human_genes:R:RPL36A-HNRNPH2|RPL36A-HNRNPH2]]|2.24|0.80| |[[:human_genes:P:POLE2|POLE2]]|2.25|0.58| |[[:human_genes:U:UGGT1|UGGT1]]|2.29|0.27| |[[:human_genes:N:NXF1|NXF1]]|2.30|0.50| |[[:human_genes:F:FAU|FAU]]|2.35|0.50| |[[:human_genes:N:NLK|NLK]]|2.37|0.50| |[[:human_genes:T:TMEM230|TMEM230]]|2.51|0.23| |[[:human_genes:N:NPRL2|NPRL2]]|2.67|0.23| |[[:human_genes:N:NUP88|NUP88]]|2.82|0.08| |[[:human_genes:N:NPC1|NPC1]]|3.76|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|0.064|| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|0.062|| |[[:results:exp149|SB203580 25μM R03 exp149]]|0.054|| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|0.054|| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|0.071|| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|0.054|| |[[:results:exp124|GSK343 3μM R03 exp124]]|0.053|| |[[:results:exp433|LJH685 50μM R08 exp433]]|0.051|| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|0.051|| {{:chemogenomics:comparison_plots:exp506_vs_exp508.png?nolink |}} {{:chemogenomics:comparison_plots:exp506_vs_exp510.png?nolink |}} {{:chemogenomics:comparison_plots:exp149_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp422_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp233_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp352_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp124_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp433_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp506.png?nolink |}} ^GO Term^Fold Change^Genes^ |sphinganine metabolic process|591.75|SPTLC1,SPTLC2| |serine C-palmitoyltransferase activity|443.81|SPTLC1,SPTLC2,SPTSSA| |C-palmitoyltransferase activity|443.81|SPTLC1,SPTLC2,SPTSSA| |positive regulation of lipophagy|295.88|SPTLC1,SPTLC2| |regulation of lipophagy|295.88|SPTLC1,SPTLC2| |serine C-palmitoyltransferase complex|253.61|SPTLC1,SPTLC2,SPTSSA| |palmitoyltransferase complex|177.53|SPTLC1,SPTLC2,SPTSSA| |sphingoid biosynthetic process|147.94|SPTLC1,SPTLC2,SPTSSA| |sphingosine biosynthetic process|147.94|SPTLC1,SPTLC2,SPTSSA| |sphingoid metabolic process|118.35|SPTLC1,SPTLC2,KDSR,SPTSSA| |C-acyltransferase activity|98.62|SPTLC1,SPTLC2,SPTSSA| |sphingosine metabolic process|98.62|SPTLC1,SPTLC2,SPTSSA| |diol biosynthetic process|93.43|SPTLC1,SPTLC2,SPTSSA| |diol metabolic process|63.40|SPTLC1,SPTLC2,SPTSSA| |alcohol biosynthetic process|26.30|SPTLC1,SPTLC2,FDPS,SPTSSA| |ceramide metabolic process|24.66|SPTLC1,SPTLC2,SPTSSA,CERT1| |endoplasmic reticulum protein-containing complex|23.86|SPTLC1,SPTLC2,SPTSSA,EMC1,HSD17B12| |sphingolipid metabolic process|19.09|SPTLC1,SPTLC2,KDSR,SPTSSA,CERT1| |membrane lipid metabolic process|14.65|SPTLC1,SPTLC2,KDSR,SPTSSA,CERT1| ^GO Term^Fold Change^Genes^ |negative regulation of TORC1 signaling|67.35|NPC1,NPRL2,NLK,ITFG2,DEPDC5| |negative regulation of TOR signaling|41.84|NPC1,NPRL2,NLK,ITFG2,DEPDC5| |regulation of TORC1 signaling|32.11|NPC1,NPRL2,NLK,ITFG2,DEPDC5| |regulation of TOR signaling|20.46|NPC1,NPRL2,NLK,ITFG2,DEPDC5|